Literature DB >> 27694276

Dynamic contrast-enhanced MRI measurement of renal function in healthy participants.

Eli Eikefjord1,2, Erling Andersen1,3, Erlend Hodneland2,4, Erik A Hanson5, Steven Sourbron6, Einar Svarstad2,7, Arvid Lundervold1,8, Jarle T Rørvik1,2.   

Abstract

Background High repeatability, accuracy, and precision for renal function measurements need to be achieved to establish renal dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) as a clinically useful diagnostic tool. Purpose To investigate the repeatability, accuracy, and precision of DCE-MRI measured renal perfusion and glomerular filtration rate (GFR) using iohexol-GFR as the reference method. Material and Methods Twenty healthy non-smoking volunteers underwent repeated DCE-MRI and an iohexol-GFR within a period of 10 days. Single-kidney (SK) MRI measurements of perfusion (blood flow, Fb) and filtration (GFR) were derived from parenchymal intensity time curves fitted to a two-compartment filtration model. The repeatability of the SK-MRI measurements was assessed using coefficient of variation (CV). Using iohexol-GFR as reference method, the accuracy of total MR-GFR was determined by mean difference (MD) and precision by limits of agreement (LoA). Results SK-Fb (MR1, 345 ± 84; MR2, 371 ± 103 mL/100 mL/min) and SK-GFR (MR1, 52 ± 14; MR2, 54 ± 10 mL/min/1.73 m2) measurements achieved a repeatability (CV) in the range of 15-22%. With reference to iohexol-GFR, MR-GFR was determined with a low mean difference but high LoA (MR1, MD 1.5 mL/min/1.73 m2, LoA [-42, 45]; MR2, MD 6.1 mL/min/1.73 m2, LoA [-26, 38]). Eighty percent and 90% of MR-GFR measurements were determined within ± 30% of the iohexol-GFR for MR1 and MR2, respectively. Conclusion Good repeatability of SK-MRI measurements and good agreement between MR-GFR and iohexol-GFR provide a high clinical potential of DCE-MRI for renal function assessment. A moderate precision in MR-derived estimates indicates that the method cannot yet be used in clinical routine.

Entities:  

Keywords:  MR functional imaging; Urinary; adults; imaging sequence; kidney; technology assessment

Mesh:

Substances:

Year:  2016        PMID: 27694276     DOI: 10.1177/0284185116666417

Source DB:  PubMed          Journal:  Acta Radiol        ISSN: 0284-1851            Impact factor:   1.990


  5 in total

1.  Prospective pediatric study comparing glomerular filtration rate estimates based on motion-robust dynamic contrast-enhanced magnetic resonance imaging and serum creatinine (eGFR) to 99mTc DTPA.

Authors:  Sila Kurugol; Onur Afacan; Richard S Lee; Catherine M Seager; Michael A Ferguson; Deborah R Stein; Reid C Nichols; Monet Dugan; Alto Stemmer; Simon K Warfield; Jeanne S Chow
Journal:  Pediatr Radiol       Date:  2020-01-27

2.  Analysis Protocol for Dynamic Contrast Enhanced (DCE) MRI of Renal Perfusion and Filtration.

Authors:  Frank G Zöllner; Walter Dastrù; Pietro Irrera; Dario Livio Longo; Kevin M Bennett; Scott C Beeman; G Larry Bretthorst; Joel R Garbow
Journal:  Methods Mol Biol       Date:  2021

3.  Accurate Therapeutic Response Assessment of Pancreatic Ductal Adenocarcinoma Using Quantitative Dynamic Contrast-Enhanced Magnetic Resonance Imaging With a Point-of-Care Perfusion Phantom: A Pilot Study.

Authors:  Harrison Kim; Desiree E Morgan; Patrick Schexnailder; Rudolph M Navari; Grant R Williams; J Bart Rose; Yufeng Li; Ravikumar Paluri
Journal:  Invest Radiol       Date:  2019-01       Impact factor: 6.016

4.  Birth Weight Is Associated With Kidney Size in Middle-Aged Women.

Authors:  Bjørn Steinar Lillås; Tor Hatlestad Qvale; Blazej Konrad Richter; Bjørn Egil Vikse
Journal:  Kidney Int Rep       Date:  2021-09-07

5.  Multiparametric Renal MRI: An Intrasubject Test-Retest Repeatability Study.

Authors:  Anneloes de Boer; Anita A Harteveld; Bjorn Stemkens; Peter J Blankestijn; Clemens Bos; Suzanne L Franklin; Martijn Froeling; Jaap A Joles; Marianne C Verhaar; Nico van den Berg; Hans Hoogduin; Tim Leiner
Journal:  J Magn Reson Imaging       Date:  2020-04-16       Impact factor: 4.813

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.